Type 2 Diabetes Secondary to Antipsychotic Medication
Second-generation antipsychotics carry an FDA class warning about hyperglycemia and diabetes. Veterans take them for service-connected PTSD, bipolar disorder, and depression. Almost nobody connects the two on a claim form.
Direct answer
Can diabetes caused by an antipsychotic be service-connected?
Under 38 CFR 3.310, a disability resulting from treatment for a service-connected condition can itself be service-connected. Second-generation antipsychotics carry a class warning in their FDA labeling regarding hyperglycemia and new-onset type 2 diabetes — a warning the manufacturers were required to add because the association is established, not speculative. Where the VA granted a psychiatric condition, prescribed one of these medications for it, and diabetes developed during treatment, the causal chain runs back to service. Whether it holds in a particular case depends on the individual record.
Before anything else: nothing here is guidance about your own prescriptions. Do not stop or change an antipsychotic because of a VA claim or because of something you read on a website. Abrupt discontinuation carries serious risk, including relapse of the condition the VA has already recognized as disabling. Metabolic side effects are monitored and managed while treatment continues — that is a conversation with your prescriber.
The version of this I hear most often is some form of the same sentence.
"I got diabetes at thirty-six. Nobody in my family has it. I just figured that was on me."
Sometimes it is. Often nobody looked. A veteran on quetiapine for service-connected PTSD who develops diabetes eight years later has two entries in the same VA medical record — a prescription and a diagnosis — that no one has ever placed side by side, because the psychiatry clinic and the primary care clinic are not reading each other's notes with that question in mind.
This page covers one route to service connection for diabetes. It is not the only one — herbicide exposure, direct service connection, and other secondary pathways are addressed on our diabetes nexus letter page. If you served in a location covered by the Agent Orange presumption, start there instead: a presumptive claim does not require a nexus opinion at all.
What the labeling says
Is this pathway actually recognized, or is it a stretch?
It is recognized, and that distinguishes this claim from most secondary theories.
Ordinarily a secondary claim requires an examiner to accept a mechanism argued from the medical literature. Here, the association is already stated on the drug label. The FDA required a class-wide warning for second-generation antipsychotics regarding hyperglycemia and diabetes mellitus, including recommendations for glucose monitoring in patients taking them. Manufacturers do not add warnings of that kind voluntarily.
That has two consequences for a veteran.
The mechanism is not the fight. An examiner is unlikely to argue that these medications cannot affect glucose regulation, because the labeling says they can and the monitoring guidance exists precisely because of it. The dispute will be about your individual case instead.
The monitoring itself may be evidence. Where a prescriber followed metabolic monitoring guidance, there is often a series of dated fasting glucose or A1c results in the record showing the trend over time. That is the kind of documentation most secondary claims never have.
- 1A service-connected psychiatric conditionPTSD, bipolar disorder, major depressive disorder, or another rated mental health condition.
- 2A second-generation antipsychotic prescribed for itOften as an augmenting agent rather than for psychosis — which is why many veterans do not realize what class of medication they are taking.
- 3Metabolic change during treatmentRising fasting glucose, rising A1c, weight gain, or a combination — frequently documented in monitoring labs.
- 4Type 2 diabetesNow a separate condition, rated under its own diagnostic code, with its own complications.
Are you taking one of these for a rated condition?
If the VA service-connected your mental health condition, prescribed an antipsychotic for it, and you were later diagnosed with diabetes — that sequence is worth having read by a psychiatrist before you decide anything.
No fee, no obligation, and a direct answer on whether your record supports it — including when it does not.
Identifying the medication
Which medications are these, and why am I on one?
The class includes olanzapine, quetiapine, risperidone, paliperidone, aripiprazole, ziprasidone, lurasidone, asenapine, and clozapine, among others. Metabolic risk is not uniform across them — some carry substantially more than others, and that difference matters to how an individual claim is assessed.
The point most veterans are surprised by is why they are taking one at all. These medications are frequently prescribed in psychiatry for reasons other than psychosis:
- Augmentation for depressionthat has not responded to an antidepressant alone
- Mood stabilizationin bipolar disorder
- Adjunctive treatment in PTSD, particularly for irritability, hypervigilance, or intrusive symptoms
- Sleep — low-dose quetiapine is very widely used this way
- Anxiety where other agents have failed or are not appropriate
A veteran handed quetiapine for sleep by a VA psychiatry clinic is often never told it belongs to a class with a metabolic warning, because at low doses the conversation does not always happen. If a medication on your list is one of these, that is worth knowing regardless of what it was prescribed for.
In plain terms
You do not have to have been psychotic to be on an antipsychotic. Most veterans in this situation were given one for sleep, for mood, or as an add-on — and the metabolic risk does not depend on the reason it was prescribed.
The common objection
What if I gained weight — doesn't that explain it?
This is the argument you should expect to meet, and it is worth understanding before you file.
The examiner's position will usually be some version of: the veteran gained weight, obesity causes diabetes, therefore the diabetes is attributable to weight rather than to the medication — and VA has long held that obesity is not itself a disability for compensation purposes.
Two things are worth knowing in response.
Weight gain from these medications is not an unrelated event. Where a service-connected condition's treatment causes weight gain, and that weight gain contributes to a further condition, VA General Counsel has addressed obesity's role as an intermediate step in a causal chain — see VAOPGCPREC 1-2017 and Walsh v. Wilkie. That obesity is not independently compensable does not mean it cannot sit in the middle of a chain that is.
Weight is not the whole mechanism. The metabolic effects of this drug class are understood to operate partly independently of weight change — which is why the labeling and monitoring guidance are not limited to patients who gain weight. A veteran whose weight was stable and whose glucose still rose has a real argument, and it is one an opinion has to build carefully from the individual record rather than assert.
How that argument is actually constructed in a given case is the substance of the medical opinion, and it depends entirely on what the labs, the weights, the doses, and the dates show. It is not something to work out from a web page.
One thing worth knowing if weight gain is part of your picture: diabetes is not the only condition downstream of it. Treatment-related weight gain also bears on obstructive sleep apnea, which follows the same intermediate-step reasoning and is frequently claimable in the same file. A veteran who gained sixty pounds on an antipsychotic and now has both diabetes and sleep apnea has one cause and two potential claims.
Building the claim
What does the record have to show?
- 1
The psychiatric condition is service-connected
The rating decision granting it, at any percentage. Without the anchor there is no secondary claim.
- 2
The medication, with dates and doses
Pharmacy records showing which agent, at what dose, starting when, and for how long. Duration and dose both matter, and this is usually the easiest part of the file to obtain.
- 3
The metabolic trend, not just the diagnosis
Fasting glucose and A1c results over time, and recorded weights. A single abnormal value is a data point; a series is a trajectory, and a trajectory is what makes the timing assessable. Where metabolic monitoring was done, these already exist.
- 4
What the picture looked like before the prescription
Baseline glucose, baseline weight, and whether any prediabetic range values predate the medication. This cuts both ways and should be gathered honestly — it is the first thing a competent reviewer will look for.
- 5
The diabetes diagnosis and current treatment
Date of diagnosis, current regimen, and any complications. Treatment intensity drives the evaluation, which is discussed below.
- 6
Other contributors, named
Family history, other medications, diet and activity, other medical conditions. An opinion that pretends the antipsychotic was the only variable reads as advocacy and gets treated accordingly.
Eating patterns deserve particular care here. Increased appetite is a recognized effect of several of these medications, and that is different from a distinct eating disorder — though the two can coexist, and either can be present alongside a service-connected psychiatric condition. Sorting out which is operating matters for the opinion, and it matters more for your care. We cover the distinction in emotional eating versus binge eating.
If some of this is missing, it is often obtainable. Metabolic labs sit in primary care records rather than psychiatry notes, which is one reason veterans assume the documentation does not exist when it does.
Evaluation
What is a diabetes claim worth?
Diabetes is rated under 38 CFR 4.119, Diagnostic Code 7913, from 10 to 100 percent. The criteria are successive — each level requires everything below it plus more, which the Federal Circuit confirmed in Middleton v. Shinseki, 727 F.3d 1172 (Fed. Cir. 2013).
| Evaluation | Criteria |
|---|---|
| 10% | Manageable by restricted diet only |
| 20% | Requiring insulin and restricted diet, or oral hypoglycemic agent and restricted diet |
| 40% | Requiring insulin, restricted diet, and regulation of activities |
| 60% | The above, with episodes of ketoacidosis or hypoglycemic reactions requiring one or two hospitalizations per year or twice-monthly visits to a diabetic care provider, plus complications that would not be compensable if separately evaluated |
| 100% | More than one daily insulin injection, restricted diet, and regulation of activities, with episodes requiring at least three hospitalizations per year or weekly provider visits, plus either progressive loss of weight and strength or compensable complications |
Summary of 38 CFR 4.119, DC 7913. The VA assigns the evaluation.
Two things decide most diabetes evaluations.
The first is regulation of activities, the criterion separating 20 percent from 40. It has a specific legal meaning: a physician must have prescribed avoidance of strenuous occupational and recreational activities because of the diabetes. Being tired, or generally advised to take it easy, does not satisfy it. Camacho v. Nicholson, 21 Vet. App. 360 (2007), requires medical evidence establishing it. Many veterans on insulin sit at 20 percent solely because this was never documented.
The second is that complications are rated separately. Under Note (1) to DC 7913, compensable complications are evaluated separately unless they are part of the criteria supporting a 100 percent rating. Peripheral neuropathy — potentially in all four extremities — along with retinopathy, nephropathy, and erectile dysfunction each carry their own evaluations. In practice the complications frequently exceed the diabetes rating itself.
Why this claim matters more than it looks
A psychiatric condition establishes diabetes, and diabetes opens a whole further set of separately rated conditions. Among medication-pathway claims, this one has the longest tail.
Our diabetes nexus letter page covers the evaluation criteria and the complication ratings in more detail, along with the other routes to service connection.
The opinion
Why this one needs a physician
The claim looks simple from outside — a warning label, a prescription, a diagnosis. What decides it is none of those things.
It is the individual reconstruction: which agent at which dose for how long, what the glucose trajectory actually did relative to the start of treatment, what the weight did alongside it, what the baseline was, which other contributors are present in the record, and whether the timing supports the conclusion or undercuts it. That analysis requires reading laboratory data against a medication timeline and knowing what the drug in question does — and it has to survive a reviewer who will look first for the pre-existing risk factor that explains everything more simply.
Under Nieves-Rodriguez v. Peake, 22 Vet. App. 295 (2008), the weight an opinion carries comes from its reasoning, the examiner's familiarity with the facts, and their training. On a claim that turns on pharmacology and laboratory interpretation, those are not incidental.
Dr. Allen writes every opinion this practice produces herself. Where the record does not support the pathway — and in a meaningful share of these cases it does not — she says so at the consultation, before any fee.
Have the record read before you file
Send the rating decision, your medication list, and whatever lab work you have. You will get a direct answer about whether the pathway fits your case.
FAQ
Frequently asked questions about diabetes and antipsychotic medication
Can diabetes be secondary to PTSD medication?
Which medications are second-generation antipsychotics?
I was told this medication was for sleep. Does that change anything?
I gained a lot of weight on it. Does that hurt or help?
My weight didn't change but I still got diabetes. Is that a weaker claim?
What records will I need?
Should I stop the medication?
How is diabetes rated?
What about the complications?
Does everyone on these medications have this claim?
Where to go next
Related pages
About the author
Jessica R. Allen, M.D.
Licensed psychiatrist and former VA Compensation and Pension examiner · Brightview Psychiatry Solutions PLLC, Wake Forest, North Carolina
Dr. Allen spent three years conducting Compensation and Pension examinations for the VA, and has spent the six years since writing independent medical opinions for veterans. She prescribes and monitors these medications, which is a different thing from having read about them — and it is what makes the metabolic timeline in a veteran's chart legible rather than just present. More about Dr. Allen.
Start with a free consultation
Bring the rating decision, your medication list, and whatever lab work you have. Dr. Allen will tell you whether the pathway is supportable — including when it is not.
Brightview Psychiatry Solutions PLLC provides independent medical opinions and psychiatric evaluations. This page is educational and is not medical or legal advice, and does not create a physician-patient relationship. VA determines service connection and assigns all disability evaluations. No outcome is guaranteed.